lif
LIF, GST |
|||
cyt-001 | ProSpec Tany | 2µg | 60 EUR |
Description: Recombinant Human Leukemia Inhibitory Factor, GST tag |
|||
LIF, Sf9 |
|||
cyt-1003 | ProSpec Tany | 2µg | 60 EUR |
Description: Recombinant Human Leukemia Inhibitory Factor, Sf9 |
|||
LIF, His |
|||
cyt-1082 | ProSpec Tany | 2µg | 60 EUR |
Description: Recombinant Human Leukemia Inhibitory Factor, His tag |
|||
rHu LIF |
|||
AK9977-0005 | Akron Biotech | 5µg | Ask for price |
rHu LIF |
|||
AK9977-0025 | Akron Biotech | 25µg | Ask for price |
rHu LIF |
|||
AK9977-0100 | Akron Biotech | 100µg | Ask for price |
rHu LIF |
|||
AK9977-1000 | Akron Biotech | 1mg | Ask for price |
LIF,Mouse |
|||
E34M066M | EnoGene | 5 μg | 155 EUR |
LIF,Human |
|||
E34M169H | EnoGene | 5 μg | 155 EUR |
LIF, Yeast |
|||
cyt-191 | ProSpec Tany | 5µg | 60 EUR |
Description: Recombinant Human Leukemia Inhibitory Factor, Yeast |
|||
LIF siRNA |
|||
20-abx922546 | Abbexa |
|
|
LIF siRNA |
|||
20-abx922547 | Abbexa |
|
|
LIF, human |
|||
MO16101 | Neuromics | 100 ug | 825.6 EUR |
LIF, mouse |
|||
MO16102 | Neuromics | 100 ug | 810 EUR |
LIF, Human |
|||
HY-P7049 | MedChemExpress | 10ug | 1920 EUR |
LIF, Mouse |
|||
HY-P7084 | MedChemExpress | 50ug | 639.6 EUR |
LIF Peptide |
|||
6245P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) LIF peptide |
|||
LIF protein |
|||
30R-2771 | Fitzgerald | 10 ug | 329 EUR |
Description: Purified recombinant Human LIF protein |
|||
LIF protein |
|||
30R-2772 | Fitzgerald | 10 ug | 413 EUR |
Description: Purified recombinant Mouse LIF protein |
|||
LIF Peptide |
|||
43-200P | ProSci | 0.1 mg | 405.6 EUR |
LIF Antibody |
|||
6245-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
LIF Antibody |
|||
6245-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
LIF Antibody |
|||
25283-100ul | SAB | 100ul | 468 EUR |
LIF Antibody |
|||
1-CSB-PA012928ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
LIF Antibody |
|||
E036950 | EnoGene | 100μg/100μl | 255 EUR |
Description: Available in various conjugation types. |
|||
LIF Antibody |
|||
F49998-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
LIF Antibody |
|||
F49998-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
LIF Antibody |
|||
E38PA4058 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
LIF Antibody |
|||
E315544 | EnoGene | 100ug/200ul | 295 EUR |
Description: Available in various conjugation types. |
|||
LIF Antibody |
|||
E91288 | EnoGene | 100μg | 255 EUR |
Description: Available in various conjugation types. |
|||
LIF Antibody |
|||
DF13730 | Affbiotech | 100ul | 420 EUR |
LIF Antibody |
|||
DF13730-100ul | Affinity Biosciences | 100ul | 280 EUR |
LIF Antibody |
|||
DF13730-200ul | Affinity Biosciences | 200ul | 350 EUR |
LIF Antibody |
|||
1-CSB-PA004761 | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
LIF Antibody |
|||
36950 | SAB | 100ul | 319 EUR |
LIF Antibody |
|||
36950-100ul | SAB | 100ul | 302.4 EUR |
LIF Antibody |
|||
5216-100 | Biovision | each | 379.2 EUR |
LIF Antibody |
|||
5216-30T | Biovision | each | 175.2 EUR |
LIF antibody |
|||
70R-14100 | Fitzgerald | 100 ug | 519 EUR |
Description: Affinity purified Rabbit polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-6230 | Fitzgerald | 50 ug | 467 EUR |
Description: Rabbit polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-51295 | Fitzgerald | 100 ul | 242 EUR |
Description: Purified Polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-12299 | Fitzgerald | 100 ug | 343 EUR |
Description: Rabbit polyclonal LIF antibody |
|||
LIF Antibody |
|||
1-CSB-PA198481 | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
|||
LIF Antibody |
|||
GWB-MT498C | GenWay Biotech | 50ug | Ask for price |
LIF Antibody |
|||
R30639 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. It is produced in high amounts by the human endometrium and the trophoblast itself, and its receptors are present on cytotrophoblast cells. LIF could thus play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. |
|||
LIF Antibody |
|||
R31467 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. This gene is mapped to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. It could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. |
|||
LIF Antibody |
|||
R36251-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
Description: Additional name(s) for this target protein: Leukemia inhibitory factor |
|||
LIF antibody |
|||
PAab09804 | Lifescience Market | 100 ug | 463.2 EUR |
LIF Rabbit pAb |
|||
E2251831 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
LIF Rabbit pAb |
|||
E2501288 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
LIF Rabbit pAb |
|||
A1288-100ul | Abclonal | 100 ul | 369.6 EUR |
LIF Rabbit pAb |
|||
A1288-200ul | Abclonal | 200 ul | 550.8 EUR |
LIF Rabbit pAb |
|||
A1288-20ul | Abclonal | 20 ul | 219.6 EUR |
LIF Rabbit pAb |
|||
A1288-50ul | Abclonal | 50 ul | 267.6 EUR |
anti- LIF antibody |
|||
FNab09804 | FN Test | 100µg | 658.5 EUR |
Description: Antibody raised against LIF |
|||
Mouse LIF Protein |
|||
E40MOP1672 | EnoGene | 20ug | 495 EUR |
Mouse LIF Protein |
|||
E40MOP2026 | EnoGene | 20ug | 495 EUR |
Mouse LIF Protein |
|||
E40MOP2028 | EnoGene | 20ug | 495 EUR |
anti- LIF antibody |
|||
LSMab09804 | Lifescience Market | 100 ug | 463.2 EUR |
Recombinant Rat LIF |
|||
REOPP-1201 | Cyagen | 5ug | Ask for price |
LIF Blocking Peptide |
|||
33R-4712 | Fitzgerald | 100 ug | 119 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody, catalog no. 70R-6230 |
|||
LIF Blocking Peptide |
|||
20-abx064170 | Abbexa |
|
|
Recombinant Human LIF |
|||
EPT153 | ELK Biotech | 10ug | 119.4 EUR |
Description: Recombinant Human Leukemia Inhibitory Factor is produced by our E.coli expression system and the target gene encoding Ser23-Phe202 is expressed. |
|||
LIF, human recombinant |
|||
4923-10 | Biovision | each | 366 EUR |
LIF, human recombinant |
|||
4923-1000 | Biovision | each | 6846 EUR |
LIF, human recombinant |
|||
4923-50 | Biovision | each | 796.8 EUR |
Recombinant Human LIF |
|||
HEOPP-1202 | Cyagen | 5ug | Ask for price |
Recombinant Human LIF |
|||
Z100605 | ABM | 10 µg | 85 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Human LIF |
|||
Z100607 | ABM | 100 µg | 360 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Human LIF |
|||
Z100609 | ABM | 1.0 mg | 1500 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Mouse LIF |
|||
Z200195 | ABM | 10 µg | 85 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Mouse LIF |
|||
Z200197 | ABM | 100 µg | 385 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Mouse LIF |
|||
Z200199 | ABM | 1.0 mg | 1200 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
Recombinant Mouse LIF |
|||
Z200485 | ABM | 100 µg | 1500 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
|||
LIF, murine recombinant |
|||
4924-10 | Biovision | each | 444 EUR |
LIF, murine recombinant |
|||
4924-1000 | Biovision | each | 8203.2 EUR |
Recombinant Murine LIF |
|||
MEOPP-1201 | Cyagen | 5ug | Ask for price |
LIF Polyclonal Antibody |
|||
41551 | SAB | 100ul | 319 EUR |
LIF Polyclonal Antibody |
|||
41551-100ul | SAB | 100ul | 302.4 EUR |
LIF Polyclonal Antibody |
|||
41551-50ul | SAB | 50ul | 224.4 EUR |
LIF Recombinant Protein |
|||
40-682 | ProSci | 5 ug | 311.1 EUR |
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Murine LIF is a 19.9 kDa protein containing 180 amino acids residues, including three disulfide bonds. |
|||
LIF Recombinant Protein |
|||
40-684 | ProSci | 5 ug | 311.1 EUR |
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Human LIF is a 19.7 kDa protein containing 180 amino acid residues, including three disulfide bonds. |
|||
LIF Polyclonal Antibody |
|||
E041551 | EnoGene | 100μg/100μl | 255 EUR |
Description: Available in various conjugation types. |
|||
LIF Polyclonal Antibody |
|||
E20-75107 | EnoGene | 100ug | 225 EUR |
Description: Available in various conjugation types. |
|||
Polyclonal LIF Antibody |
|||
APR00279G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal LIF Antibody |
|||
APR06696G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
|||
LIF Polyclonal Antibody |
|||
ABP52838-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Polyclonal Antibody |
|||
ABP52838-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Polyclonal Antibody |
|||
ABP52838-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Conjugated Antibody |
|||
C36950 | SAB | 100ul | 476.4 EUR |
LIF Recombinant Protein |
|||
90-277 | ProSci | 10 ug | 405.6 EUR |
Description: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities also include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation and the stimulation of acute-phase protein synthesis in hepatocytes. LIF activates JAK & STAT signaling in human embryonic stem (ES) cells, but this pathway does not maintain pluripotency in these cells, which instead rely on FGF2-mediated ERK signaling. By contrast, mouse ES cells can be maintained by LIF-mediated JAK & STAT signaling. LIF binds to a high affinity heterodimeric receptor complex consisting of two proteins: LIF-R alpha that binds LIF with low affinity and the 130kDa (gp130) subunit that by itself does not bind LIF, but is required for high affinity binding of LIF. |
|||
LIF Recombinant Protein |
|||
91-014 | ProSci | 0.05 mg | 651.3 EUR |
Description: Leukemia Inhibitory Factor (LIF) is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Human and murine mature LIF exhibit a 78% sequence identity at the amino acid level. Human LIF is equally active on human and mouse cells. Murine LIF is approximately 1000 fold less active on human cells than human LIF. |
|||
LIF Recombinant Protein |
|||
91-575 | ProSci | 0.05 mg | 588.3 EUR |
Description: Mouse Leukemia inhibitory factor(lif)is a secreted protein which belongs to the LIF/OSM family.LIF has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. it has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes. |
|||
LIF Recombinant Protein |
|||
97-011 | ProSci | 0.02 mg | 468.6 EUR |
Description: Leukemia inhibitory factor, or LIF, an interleukin 6 class cytokine, is a protein in cells that affects cell growth and development.Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. Therefore LIF is used in mouse embryonic stem cell culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for LIF independent growth, notably overexpression of the gene Nanog. LIF is not required for culture of human embryonic stem cells. |
|||
Recombinant Porcine LIF |
|||
Z400015 | ABM | 10 µg | 85 EUR |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL6 family of cytokines, which also includes IL11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |